ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
CERo Therapeutics Holdings Inc

CERo Therapeutics Holdings Inc (CERO)

0.2023
0.00
(0.00%)
終了 11月29日 6:00AM
0.00
0.00
(0.00%)
取引時間後: -

個人投資家向けのプロ仕様のツール。

主要統計と詳細

通貨
0.2023
買値
0.1906
売値
0.1938
出来高
-
0.00 日の範囲 0.00
0.0636 52 週間の範囲 12.38
前日終値
0.2023
始値
-
時刻
最終取引時間
平均取引量 (3 か月)
69,217,126
財務取引量
-
VWAP
-

CERO 最新ニュース

CERo Therapeutics, Inc. Receives FDA Clearance of Investigational New Drug Application to Initiate Phase 1 Clinical Trial of Its Lead Compound CER-1236 in Acute Myelogenous Leukemia

SOUTH SAN FRANCISCO, Calif, Nov. 15, 2024 (GLOBE NEWSWIRE) --  CERo Therapeutics Holdings, Inc. (Nasdaq: CERO) (“CERo”), an innovative immunotherapy company seeking to advance the next...

CERo Therapeutics, Inc. Presents Preclinical Data Demonstrating CER-1236 Killing Ovarian Cancer Cell Lines Without Toxicity

Data presented as part of a poster at the SITC 2024 Conference SOUTH SAN FRANCISCO, Calif., Nov. 11, 2024 (GLOBE NEWSWIRE) --  CERo Therapeutics Holdings, Inc. (Nasdaq: CERO) (“CERo”), an...

CERo Therapeutics, Inc. Provides Corporate Update

Company announces submission of IND Clinical Hold Complete Response Letter SOUTH SAN FRANCISCO, Calif., Oct. 21, 2024 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc. (Nasdaq: CERO...

CERo Therapeutics, Inc. Names Al Kucharchuk Chief Financial Officer and Kristen Pierce Chief Development Officer

SOUTH SAN FRANCISCO, Calif, Oct. 02, 2024 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc. (Nasdaq: CERO) (“CERo”), an innovative immunotherapy company seeking to advance the next generation...

CERo Therapeutics, Inc. Announces Financing and Provides Update on Investigational New Drug Application for CER-1236

Company requests Type A Meeting with U.S. Food and Drug Administration regarding clinical hold for CER-1236; announces key management changes SOUTH SAN FRANCISCO, Calif., Sept. 25, 2024 (GLOBE...

CERo Therapeutics, Inc. Presents CER-1236 Data Supporting Use in AML at Global Cell & Gene Therapy Summit 2024

Company anticipates initial human trials to focus on AML upon IND clearance SOUTH SAN FRANCISCO, Calif., July 08, 2024 (GLOBE NEWSWIRE) --  CERo Therapeutics Holdings, Inc. (Nasdaq: CERO...

CERo Therapeutics, Inc. Completes IND-Enabling Activities Following Successful Manufacturing Runs for Lead Compound CER-1236

Company anticipates near term filing of Investigational New Drug Application to FDA SOUTH SAN FRANCISCO, Calif., June 13, 2024 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc. (Nasdaq:...

CERo Therapeutics, Inc. Successfully Completes IND-Enabling Toxicology Studies for Lead Compound CER-1236

Company continuing IND-enabling activities in preparation for submission of Investigational New Drug Application to FDA SOUTH SAN FRANCISCO, Calif., June 06, 2024 (GLOBE NEWSWIRE) --  CERo...

CERo Therapeutics, Inc. Provides Corporate Update for Shareholders

SOUTH SAN FRANCISCO, Calif., May 15, 2024 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (Nasdaq:CERO) (“CERo”) an innovative immunotherapy company seeking to advance the next generation...

CERo Therapeutics, Inc. Presents Encouraging Preclinical Data for AML on CER-1236 at Stanford Drug Discovery Symposium Highlighting Tumor Elimination and Manufacturing Attributes

SOUTH SAN FRANCISCO, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (NASDAQ:CERO) (“CERo”) an innovative immunotherapy company seeking to advance the next...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.03-12.91433491180.23230.25490.1411201686290.19806332CS
40.1272169.3741677760.07510.44770.06361829315230.24065144CS
120.092183.57531760440.11020.44770.0636692171260.22431238CS
26-0.8377-80.54807692311.041.07990.0636350509940.22468165CS
52-5.0477-96.14666666675.2512.380.0636228932850.26761256CS
156-5.0477-96.14666666675.2512.380.0636228932850.26761256CS
260-5.0477-96.14666666675.2512.380.0636228932850.26761256CS

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
VCIGVCI Global Ltd
US$ 4.1092
(129.56%)
257.18M
IDAIT Stamp Inc
US$ 0.835
(128.77%)
369.69M
WAITop KingWin Ltd
US$ 0.43
(79.17%)
121.91M
HWHHWH International Inc
US$ 0.918
(62.48%)
32.06M
PROCProcaps Group SA
US$ 2.149
(58.01%)
210.26k
PGHLPrimega Group Holdings Ltd
US$ 1.6455
(-98.47%)
43.2M
OTLKOutlook Therapeutics Inc
US$ 1.695
(-65.34%)
61.98M
IMGCIMG Inc
US$ 0.8831
(-44.81%)
5.22M
KDLYKindly MD Inc
US$ 1.075
(-43.12%)
3.54M
HAOHaoxi Health Technology Ltd
US$ 0.13
(-36.59%)
36.86M
IDAIT Stamp Inc
US$ 0.835
(128.77%)
374.4M
VCIGVCI Global Ltd
US$ 4.1092
(129.56%)
257.58M
NVDANVIDIA Corporation
US$ 135.34
(-1.15%)
226.41M
WAITop KingWin Ltd
US$ 0.43
(79.17%)
121.92M
MARAMARA Holdings Inc
US$ 26.915
(7.79%)
87.94M

CERO Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock